학술논문

Phase I/II trial of cabazitaxel plus abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel and abiraterone
Document Type
Article
Source
In Annals of Oncology January 2017 28(1):90-95
Subject
Language
ISSN
0923-7534